We have decades of experience in analyzing small and mid-cap stocks as well as disseminating this information to retail investors. With investment cases, we provide free information on investment opportunities within the segment of Nordic small and mid-caps companies for primarily a Nordic investing audience.
If you want to contact us directly, find contact details for the individual employee under Line Up.
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week the Nordic healthcare
Through a private placement at market price, FluoGuide raises SEK 60M to initiate planned Phase II trials and trigger the
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, the KPHC
The Mobility sector is the one and only this year performing exceptionally well with a 38% return year-to-date. Clean Motion
In the past week, the Mobility and Energy Production & Storage sectors did very well – again. The best-performing stock
In the past week, the Mobility and Energy Production & Storage sectors did very well. The best-performing stocks were driven
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week, Genmab and
NORDIC | BIOTECH & HEALTHCARE Your insights into listed Danish & Nordic biotech & healthcare stocks. Last week was full
Kapital Partner performs or has within the last 12 months performed corporate finance, market relations, investor relations, Certified Adviser or other advisory activities for the following listed companies: NORD.investments, Biosergen, InterMail, Pila Pharma, Hypefactors, Curasight, Evaxion, Re-Match, Audientes, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.